Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,88116,900 of 20,252 grants

Active NON-SBIR/STTR RPGS
Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2026

Abstract Acute lymphoblastic leukemia (ALL) is the most common cancer in children, with T-cell ALL accounting for 15% of cases. T-ALL in children is associated with aggressive clin...

$5.87M
USD
Active NON-SBIR/STTR RPGS
Adapting and implementing evidence-based breast cancer follow-up in primary care
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Breast cancer survivors are a growing population and their symptom burden is significant. Despite growing evidence on specific symptoms and risk management...

$6.36M
USD
Active NON-SBIR/STTR RPGS
Metabolic Control and Anticancer Mechanism
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

ABSTRACT As a central controller of cancer growth and metabolism, mTORC1 pathway is commonly mutated and activated in human cancer, leading to uncontrolled growth. Cancer cells are...

$3.34M
USD
Active NON-SBIR/STTR RPGS
Development of AMPK Inhibitors for the treatment of leukemia
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2026

PROJECT SUMMARY Despite advances in the treatment of acute myeloid leukemia (AML), only 20–30% of patients achieve long-term disease-free survival (DFS) and treatment options for r...

$3.4M
USD
Active NON-SBIR/STTR RPGS
Real time colon histopathology by infrared spectroscopic imaging
NATIONAL CANCER INSTITUTE University of Illinois At Urbana-Champai... United States 2021 – 2026

Abstract Colorectal cancer (CRC) is one of the leading causes of death in the US. Active screening and early intervention in risky cancers can lead to good outcomes; however, a bot...

$4.66M
USD
Active NON-SBIR/STTR RPGS
Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy
NATIONAL CANCER INSTITUTE University of Chicago United States 2021 – 2026

Project Summary Cancer is a leading cause of death worldwide. Recent advancements in the use of immune checkpoint blockade have transformed oncology, and immunotherapy has extended...

$4.04M
USD
Active NON-SBIR/STTR RPGS
Hexokinase 2 and cancer therapy
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2021 – 2026

Cancer cells are metabolically different from normal matching cells, and this is manifested by the high rate of glucose metabolism in cancer cells. The high rate of glucose metabol...

$5.63M
USD
Active NON-SBIR/STTR RPGS
Ethnicity and Lung Cancer Survival: A Test of the Hispanic Sociocultural Hypothesis
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT As the leading cause of cancer death, lung cancer represents the most significant cancer-related public health challenge in the United States. Although low...

$6.41M
USD
Active NON-SBIR/STTR RPGS
Statistical methods for cancer mutational signatures
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

Project Summary Carcinogens and evolutionary pressures generate unique patterns in the types of somatic mutations observed in the DNA of cancer cells. Mutational signature analysis...

$2.31M
USD
Active NON-SBIR/STTR RPGS
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

Abstract Mantle cell lymphoma (MCL) accounts for 6-8% of all non-Hodgkin lymphomas (NHLs). While substantial therapeutic advances have been achieved for other NHLs, MCL remains an...

$3.94M
USD
Active NON-SBIR/STTR RPGS
Pentraxin-3 in the Pathogenesis and Management of Triple-Negative Breast Cancer
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

SUMMARY Background. Triple-negative breast cancers (TNBCs) present with advanced histological grade and aggressive clinical behavior. They are overwhelmingly unresponsive to conven...

$4.54M
USD
Completed TRAINING, INDIVIDUAL
The oncogenic functions of Neuropilin-1 in the glioblastoma tumor microenvironment
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2021 – 2025

Abstract Glioblastoma (GB) is the most common primary tumor of the central nervous system (CNS) in adults. Despite aggressive surgery, radiation, and chemotherapy, median survival...

$526.9K
USD
Active NON-SBIR/STTR RPGS
Persistent STAT5 signaling in polyfunctional CD4 T cells and its application in adoptive T cell therapy
NATIONAL CANCER INSTITUTE Augusta University United States 2021 – 2026

Project summary/abstract Recent advances in adoptive T-cell therapy (ACT), especially CD19-targeting chimeric antigen receptor (CAR) T-cell therapy (CD19CART), have highlighted the...

$5.12M
USD
Completed NON-SBIR/STTR RPGS
Dissecting the oncogenic and pro-metastatic roles of PTHLH-mediated calcium signaling in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2021 – 2025

PROJECT SUMMARY Pancreatic cancer is a major health issue in the US, with only 7% of patients surviving beyond 5-years and nearly all patients presenting with metastases. Identifyi...

$2.49M
USD
Completed NON-SBIR/STTR RPGS
Dynamic prediction incorporating time-varying covariates for the onset of breast cancer
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2025

PROJECT SUMMARY Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited treatment options and poor survival. Approximately 12% to 17% of women w...

$2.1M
USD
Active NON-SBIR/STTR RPGS
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

SUMMARY Hepatocellular carcinoma (HCC) is a major health problem, with increasing mortality rates. In the US, HCC mortality is strongly affected by race/ethnicity and the highest m...

$2.54M
USD
Active NON-SBIR/STTR RPGS
CONNECT: COmpreheNsive traiNing and Engagement in Cessation Treatment
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2027

PROJECT SUMMARY Adult smoking prevalence in the United States (US) is approximately 14% nationwide, yet significant disparities persist, including among adults with annual househol...

$5.9M
USD
Active TRAINING, INDIVIDUAL
Decoding the Tissue of Origin of Cellular Damage from Cell-free DNA in Liquid Biopsies
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2026

ABSTRACT Liquid biopsy applications are rapidly emerging as a minimally invasive approach to collect system-wide representative analytes for genomic monitoring of physiologic and d...

$539.7K
USD
Active NON-SBIR/STTR RPGS
Personalized Adoptive T-cell Therapy for AML
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2021 – 2026

Abstract/Project Summary The development of strategies to expand and activate AML specific T cells is of critical importance. We have developed a personalized cancer vaccine in whi...

$6.92M
USD
Completed NON SBIR/STTR CONTRACTS
TASK ORDER 75N91021F00001 FOR SUPPORT SERVICES FOR DEVELOPING AND PROMOTING METHODS AND STANDARDS FOR CANCER REGISTRY OPERATIONS AND SURVEILLANCE DATA
NATIONAL CANCER INSTITUTE North American Assn/Central Cancer Reg United States 2021 – 2023

The objective of this contract is to provide support to the North American Association of Central Cancer Registries (NAACCR) in order to make the National Cancer Institute’s (NCI)...

$17.86M
USD